During the past decade, West Tallinn Central Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 21 clinical trials were completed, i.e. on average, 80.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 14 clinical trials were completed. i.e. 280% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Tallinn Central Hospital" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Shire" with 5 trials sponsored, "Takeda" with 5 trials sponsored, "Celgene" with 3 trials sponsored and "Eisai Limited" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Tallinn Central Hospital" #1 collaborator was "BioMS Technology Corp." with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "ClinPhone, Inc." with 1 trials as a collaborator, "Cosmo Technologies Ltd" with 1 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "West Tallinn Central Hospital" are "Ulcerative Colitis" (10 trials), "Multiple Sclerosis" (6 trials), "Colitis, Ulcerative" (5 trials), "Crohn's Disease" (5 trials) and "Crohn Disease" (4 trials). Many other conditions were trialed in "West Tallinn Central Hospital" in a lesser frequency.

Most popular intervention types in "West Tallinn Central Hospital" are "Drug" (43 trials), "Biological" (4 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Etrolizumab" (4 trials), "Ocrelizumab" (4 trials), "Ontamalimab" (4 trials) and "Etrasimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "West Tallinn Central Hospital" are 49 trials for "All" genders.

Currently, there are NaN active trials in "West Tallinn Central Hospital". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in West Tallinn Central Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in West Tallinn Central Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

West Tallinn Central Hospital has several departments that took part in Clinical trials: "West Tallinn Central Hospital Ltd., Department of Urology" - 2 trials, "ECG Unit of West Tallinn Central Hospital" - 2 trials, "X- Ray Department of West Tallinn Central Hospital" - 2 trials, "West Tallinn Central Hospital Infectious Diseases" - 2 trials